Does RISANKIZUMAB-RZAA Cause Incorrect dose administered by device? 6 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Incorrect dose administered by device have been filed in association with RISANKIZUMAB-RZAA. This represents 0.0% of all adverse event reports for RISANKIZUMAB-RZAA.
6
Reports of Incorrect dose administered by device with RISANKIZUMAB-RZAA
0.0%
of all RISANKIZUMAB-RZAA reports
0
Deaths
0
Hospitalizations
How Dangerous Is Incorrect dose administered by device From RISANKIZUMAB-RZAA?
Of the 6 reports.
Is Incorrect dose administered by device Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Incorrect dose administered by device?
EXENATIDE (3,332)
EVOLOCUMAB (2,840)
SOMATROPIN (2,486)
ALBUTEROL (1,236)
ETANERCEPT (1,032)
SECUKINUMAB (996)
ERENUMAB-AOOE (973)
BUDESONIDE\FORMOTEROL (753)
INSULIN GLARGINE (753)
BUDESONIDE\FORMOTEROL\GLYCOPYRROLATE (674)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Incorrect dose administered by device Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA